Counterforce Health Team

Counterforce Health Team

How to Get Kuvan (Sapropterin) Covered by UnitedHealthcare in North Carolina: Forms, Appeals & Resources

Answer Box: Getting Kuvan Covered by UnitedHealthcare in North Carolina UnitedHealthcare requires prior authorization for Kuvan (sapropterin dihydrochloride) with specific medical necessity criteria. Your fastest path to approval: (1) Confirm your PKU diagnosis and phenylalanine-restricted diet documentation, (2) Submit the OptumRx prior authorization form through the UnitedHealthcare Provider Portal, and
6 min read

Renewing Arcalyst (Rilonacept) Approval with Blue Cross Blue Shield in New Jersey: Complete Guide for 2025

Answer Box: Renewing Arcalyst Coverage in New Jersey Blue Cross Blue Shield renewal of Arcalyst (rilonacept) requires updated clinical documentation showing therapeutic benefit 30 days before your current authorization expires. Key requirements include evidence of symptom improvement, normalized inflammatory markers (CRP/SAA), and lipid monitoring results. Submit renewal documentation through
7 min read

Myths vs. Facts: Getting Xospata (Gilteritinib) Covered by Aetna (CVS Health) in Georgia

Quick Answer: Getting Xospata Coverage in Georgia Fact: Aetna requires prior authorization for Xospata (gilteritinib), but approval is achievable with proper documentation. You need: confirmed FLT3 mutation testing, relapsed/refractory AML diagnosis, hematologist-oncologist prescriber, and documentation of prior therapy failures. If denied, Georgia residents have 180 days for internal appeals
6 min read

How to Get Carbaglu (Carglumic Acid) Covered by Aetna CVS Health in New York: Prior Authorization Guide and Appeals Process

Answer Box: Getting Carbaglu Covered by Aetna CVS Health in New York Aetna CVS Health covers Carbaglu (carglumic acid) for NAGS deficiency and certain organic acidemias with prior authorization. Key requirements: confirmed diagnosis via genetic/biochemical testing and documented elevated plasma ammonia levels. If denied, New York residents can appeal
5 min read